Hémoglobinurie paroxystique nocturne (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hémoglobinurie paroxystique nocturne" in French language version.

refsWebsite

Global rank French rank

3nejm.org

2,374^th place

298^th place

3wiley.com

222^nd place

129^th place

2haematologica.org

low place

1embopress.org

low place

9,137^th place

1sciencedirect.com

149^th place

80^th place

1nih.gov

4^th place

12^th place

1ashpublications.org

low place

1nature.com

234^th place

147^th place

1lww.com

2,769^th place

931^st place

1bloodjournal.org

low place

4,294^th place

ashpublications.org

Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ, Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria, Blood, 1993;82:1192-1196

bloodjournal.org

Kelly RJ, Hill A, Arnold LM et al. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival, Blood, 2011;117:6786-6792

embopress.org

Bessler M, Mason PJ, Hillmen P et al. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene, EMBO J, 1994;13:110-117

haematologica.org

Peffault de Latour R, Schrezenmeier H, Bacigalupo A et al. Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria, Haematologica, 2012;97:1666-1673
Hill A, Rother RP, Arnold L et al. Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization, Haematologica, 2010;95:567-573

lww.com

journals.lww.com

Fieni S, Bonfanti L, Gramellini D, Benassi L, Delsignore R, Clinical management of paroxysmal nocturnal hemoglobinuria in pregnancy: a case report and updated review, Obstet Gynecol Surv, 2006;61:593-601

nature.com

Hill A, DeZern AE, Kinoshita T, Brodsky RA, Paroxysmal nocturnal haemoglobinuria, Nat Rev Dis Primers, 2017;3:17028-17028

nejm.org

Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV, Natural history of paroxysmal nocturnal hemoglobinuria, N Engl J Med, 1995;333:1253-1258
Hillmen P, Szer J, Weitz I et al. Pegcetacoplan versus eculizumab in paroxysmal nocturnal hemoglobinuria, N Eng J Med, 2021;384:1028-1037
Peffault de Latour R, Röth A, Kulasekararaj AG et al. Oral iptacopan monotherapy in paroxysmal nocturnal hemoglobinuria, N Eng J Med, 2024;390:994-1008

nih.gov

pubmed.ncbi.nlm.nih.gov

Kinoshita T, Medof ME, Nussenzweig V, Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes, J Immunol, 1986;136:3390-3395

sciencedirect.com

Takeda J, Miyata T, Kawagoe K et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria, Cell, 1993;73:703-711

wiley.com

onlinelibrary.wiley.com

(en) Borowitz MJ, Craig FE, Digiuseppe JA et al. « Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry », Cytometry B Clin Cytom. 2010;78:211-230
Loschi M, Porcher R, Barraco F et al. Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study, Am J Hematol, 2016;91:366-370
Kulasekararaj AG, Griffin M, Langemeijer S et al. Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies, Eur J Haematol, 2022;109:205-214